查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1869712

病毒攜帶者篩檢市場規模、佔有率和趨勢分析報告：按疾病、類型、技術、應用、地區和細分市場預測（2025-2033 年）

Carrier Screening Market Size, Share & Trends Analysis Report By Medical Conditions, By Type, By Technology, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

載體篩檢市場摘要

2024 年全球病毒攜帶者篩檢市場規模估計為 15.3224 億美元，預計到 2033 年將達到 40.4529 億美元。

預計從 2025 年到 2033 年，該市場將以 11.95% 的複合年成長率成長。遺傳疾病的日益普遍、基因檢測技術的進步、人們意識的提高以及對個人化醫療的需求是推動市場成長的主要因素。

例如，根據世界衛生組織（世衛組織）的數據，大約每1,000人中就有10人患有罕見的單基因疾病，這意味著全球有7,000萬至8,000萬人患有此類疾病。光是在美國，鐮狀細胞疾病（SCD）就影響超過10萬人，在非裔美國人的盛行率明顯更高。

篩檢技術的進步，特別是次世代定序（NGS）和生物資訊學的發展，顯著提升了攜帶者篩檢市場的準確性、速度和經濟性。傳統的基因篩檢測試主要針對少數疾病，目標族群也較為單一，例如特定族群或高風險族群。相較之下，基於NGS的現代panel檢測可在單次測試中篩檢數百種基因突變，提供更廣泛、更全面的評估。例如，2025年2月，瑞士羅氏公司推出了一種名為「擴增次世代定序」（SBX）的新技術。該技術在闡明癌症、免疫系統疾病和神經退化性疾病等複雜疾病方面發揮重要作用。 SBX技術利用高通量感測器模組和合成分子來確定目標分子的DNA序列。

此外，人們對遺傳風險的日益關注以及全球範圍內向個人化醫療的轉變，正在推動攜帶者篩檢產業的擴張。個人和夫婦在管理自身生殖健康方面變得更加積極主動，並且擴大尋求遺傳諮詢與篩檢相結合。這反映出人們越來越認知到，攜帶者狀態對家庭計畫、懷孕結局以及後代的健康有著直接的影響。

攜帶者篩檢的基礎在於提高公眾意識，透過早期檢測計畫改善健康狀況。早期項目，例如在德系猶太社區開展的戴-薩克斯病篩檢，展現了教育和檢測在顯著降低疾病盛行率方面的潛力。同樣，在非裔美國人群體中開展的社區主導的鐮狀細胞病篩檢鐮狀強調了積極參與的重要性，而後來政府主導揭示了實施不力以及資訊誤導的風險。這些歷史經驗凸顯了個人化醫療的更廣泛趨勢，即個人和社區越來越傾向於尋求遺傳知識，以便做出明智的生育和醫療決策。

然而，市場面臨的主要挑戰之一是，傳統的短讀次世代定序技術難以分析基因組中的複雜區域，例如重複序列擴增、結構變異、甲基化特徵和高度同源基因。為了因應這些挑戰，包括HiFi技術在內的高精度長讀長定定序等創新技術應運而生。例如，PacBio於2025年9月宣布推出其擴展的PureTarget產品組合，用於利用HiFi定序技術進行高通量帶原者篩檢。這些解決方案透過將多種檢測方法整合到單一可擴展的測試中，簡化了工作流程，從而能夠對難以分析的基因進行精確分析。

目錄

第1章 職業篩檢市場：調查方法與範圍

2. 職業篩檢市場：執行摘要

  • 市場概述
  • 醫療狀況
  • 類型簡介
  • 技術概覽
  • 最終用途簡介
  • 競爭格局概覽

第3章 病毒篩檢市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
  • 市場促進因素分析
    • 遺傳性疾病盛行率不斷上升
    • 基因檢測技術的進步
    • 人們對個人化醫療的認知和需求日​​益成長
  • 市場限制因素分析
    • 有限的公共衛生檢測
  • 波特五力分析
  • PESTLE分析
  • 管道分析

第4章 帶因者篩檢市場：疾病預測與趨勢分析

  • 帶因者篩檢市場：疾病波動分析
  • 脊髓性肌肉萎縮症
  • 囊腫纖維化
  • 戴-薩克斯病
  • 高雪氏症
  • 鐮狀細胞性貧血症
  • 其他

第5章 病毒攜帶者篩檢市場：類型估算與趨勢分析

  • 載體篩檢市場：類型差異分析
  • 擴大攜帶者篩檢
  • 針對性疾病攜帶者的篩檢

第6章 病毒攜帶者篩檢市場：技術預測與趨勢分析

  • 病毒攜帶者篩檢市場：波動分析
  • DNA序列分析
  • 聚合酵素鏈鎖反應
  • 微陣列
  • 其他技術（MLPA、基因分型、酵素篩檢）

第7章 病毒攜帶者篩檢市場：終端使用者估算與趨勢分析

  • 載體篩檢市場：最終用途差異分析
  • 醫院
  • 研究所
  • 醫生辦公室和診所
  • 其他最終用戶

第8章 職業篩檢市場：區域業務分析

  • 區域市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

第9章 競爭情勢

  • 公司分類
  • 策略規劃
    • 新產品上市
    • 夥伴關係
    • 獲得
    • 合作
    • 資金籌措
  • 主要企業市佔率分析，2024 年
  • 公司熱力圖分析
  • 公司簡介
    • Myriad Genetics, Inc.
    • BGI Genomics
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc
    • F. Hoffmann-La Roche Ltd
    • Laboratory Corporation of America Holdings（LabCorp）
    • Otogenetics Corporation
    • MedGenome
    • GeneTech（ATS Genetech Pvt Ltd）
    • CENTOGENE GmbH
Product Code: GVR-4-68040-016-9

Carrier Screening Market Summary

The global carrier screening market size was estimated at USD 1,532.24 million in 2024 and is projected to reach USD 4,045.29 million by 2033, growing at a CAGR of 11.95% from 2025 to 2033. The rising prevalence of genetic disorders, technological advancements in genetic testing, growing awareness, and demand for personalized medicine are major factors driving the market's growth.

For instance, according to the World Health Organization, around 10 in every 1,000 individuals are affected by rare single-gene disorders, translating to between 70 million and 80 million people worldwide living with such conditions. Sickle cell disease (SCD) alone impacts more than 100,000 people in the U.S., with a particularly high prevalence among people of African American origin.

The growing technological advancement in screening techniques, particularly in next-generation sequencing (NGS) and bioinformatics, has transformed the carrier screening market by improving accuracy, speed, and affordability. Traditional genetic screening tests typically focused on a limited set of conditions, targeting specific populations or high-risk groups. In contrast, modern NGS-based panels screen hundreds of genetic mutations in a single run, providing a much broader and more comprehensive assessment. For instance, in February 2025, F. Hoffmann-La Roche AG (Switzerland) introduced a new category of next-generation sequencing by expansion (SBX) technology, which is playing a vital role in decoding complex diseases like cancer, immune disorders and neurodegenerative conditions. This technology uses high throughput sensor module along with synthetic molecules in order to determine the DNA sequence of a target molecule.

Moreover, the expansion of the carrier screening industry is propelled by rising awareness of genetic risks and the global shift toward personalized medicine. Individuals and couples are becoming increasingly proactive in managing reproductive health, seeking genetic counseling along with screening. This reflects a growing understanding that carrier status has direct implications for family planning, pregnancy outcomes, and the health of future generations.

The foundation of carrier screening lies in raising awareness to improve health outcomes through early detection programs. Early programs such as Tay-Sachs disease screening in Ashkenazi Jewish communities demonstrated how education and testing could drastically reduce disease prevalence. Similarly, community-driven sickle cell screening efforts in African American populations underscored the importance of proactive engagement, though later government-led initiatives revealed the risks of poor implementation and misinformation. These historical lessons emphasize a broader trend toward personalized medicine, where individuals and communities increasingly seek genetic insights to make informed reproductive and healthcare decisions.

However, one of the major challenges in the market emerges as traditional short-read NGS struggles with complex regions of the genome, including repeat expansions, structural variants, methylation signatures, and high-homology genes. To address these gaps, innovations such as highly accurate long-read sequencing, including HiFi technologies, are emerging. For instance, in September 2025, PacBio launched its expanded PureTarget portfolio for high-throughput carrier screening, powered by HiFi sequencing technology. The solutions streamline workflows by consolidating multiple assays into a single scalable test, enabling accurate analysis of challenging genes.

Global Carrier Screening Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global carrier screening market report based on medical conditions, type, technology, end-use, and region:

  • Medical Conditions Outlook (Revenue, USD Million, 2021 - 2033)
  • Spinal Muscular Atrophy
  • Cystic Fibrosis
  • Tay-Sachs
  • Gaucher Disease
  • Sickle Cell Disease
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Expanded Carrier Screening
  • Targeted Disease Carrier Screening
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • DNA Sequencing
  • Polymerase Chain Reaction
  • Microarrays
  • Other Technologies (MLPA, Genotyping, Enzyme Screening)
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Laboratories
  • Physician Offices & Clinics
  • Other End Users
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Carrier Screening Market: Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Medical Conditions
      • 1.1.1.2. Type Segment
      • 1.1.1.3. Technology Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objectives
    • 1.4.1. Objective - 1
    • 1.4.2. Objective - 2
    • 1.4.3. Objective - 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Carrier Screening Market: Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Medical Conditions
  • 2.3. Type Snapshot
  • 2.4. Technology Snapshot
  • 2.5. End use Snapshot
  • 2.6. Competitive Landscape Snapshot

Chapter 3. Carrier Screening Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
  • 3.4. Market Drivers Analysis
    • 3.4.1. Rising prevalence of genetic disorders
    • 3.4.2. Technological advancements in genetic testing
    • 3.4.3. Growing awareness and demand for personalized medicine
  • 3.5. Market Restraint Analysis
    • 3.5.1. Limited implementation of public health screening
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis
  • 3.8. Pipeline Analysis

Chapter 4. Carrier Screening Market: Medical Conditions Estimates & Trend Analysis

  • 4.1. Carrier Screening Market: Medical Conditions Movement Analysis
  • 4.2. Spinal Muscular Atrophy
    • 4.2.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.3. Cystic Fibrosis
    • 4.3.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Tay-Sachs
    • 4.4.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Gaucher Disease
    • 4.5.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Sickle Cell Disease
    • 4.6.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Carrier Screening Market: Type Estimates & Trend Analysis

  • 5.1. Carrier Screening Market: Type Movement Analysis
  • 5.2. Expanded Carrier Screening
    • 5.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.3. Targeted Disease Carrier Screening
    • 5.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Carrier Screening Market: Technology Estimates & Trend Analysis

  • 6.1. Carrier Screening Market: End Use Movement Analysis
  • 6.2. DNA Sequencing
    • 6.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.3. Polymerase Chain Reaction
    • 6.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.4. Microarrays
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Other Technologies (MLPA, Genotyping, Enzyme Screening)
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Carrier Screening Market: End Use Estimates & Trend Analysis

  • 7.1. Carrier Screening Market: End Use Movement Analysis
  • 7.2. Hospitals
    • 7.2.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3. Laboratories
    • 7.3.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Physician Offices & Clinics
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Other End Users
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Carrier Screening Market: Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Carrier Screening Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Reimbursement Scenario
      • 8.2.2.5. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Reimbursement Scenario
      • 8.2.3.5. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Reimbursement Scenario
      • 8.2.4.5. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. Competitive Scenario
    • 8.3.3. Germany
      • 8.3.3.1. Germany Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Competitive Scenario
    • 8.3.4. Spain
      • 8.3.4.1. Spain Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Reimbursement Scenario
      • 8.3.4.5. Competitive Scenario
    • 8.3.5. France
      • 8.3.5.1. France Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Reimbursement Scenario
      • 8.3.5.5. Competitive Scenario
    • 8.3.6. Italy
      • 8.3.6.1. Italy Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Reimbursement Scenario
      • 8.3.6.5. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Reimbursement Scenario
      • 8.3.7.5. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Reimbursement Scenario
      • 8.3.8.5. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Reimbursement Scenario
      • 8.3.9.5. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia-Pacific Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Competitive Scenario
    • 8.4.6. Thailand
      • 8.4.6.1. Thailand Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Competitive Scenario
    • 8.4.7. Australia
      • 8.4.7.1. Australia Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. Competitive Scenario
  • 8.6. Middle East & Africa
    • 8.6.1. Middle East & Africa Carrier Screening Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Carrier Screening Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement Scenario
      • 8.6.5.5. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. NEW PRODUCT LAUNCH
    • 9.2.2. PARTNERSHIPS
    • 9.2.3. ACQUISITION
    • 9.2.4. COLLABORATION
    • 9.2.5. FUNDING
  • 9.3. Key Company Market Share Analysis, 2024
  • 9.4. Company Heat Map Analysis
  • 9.5. Company Profiles
    • 9.5.1. Myriad Genetics, Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. BGI Genomics
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Illumina, Inc.
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. Thermo Fisher Scientific, Inc
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. F. Hoffmann-La Roche Ltd
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Laboratory Corporation of America Holdings (LabCorp)
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Otogenetics Corporation
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. MedGenome
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. GeneTech (ATS Genetech Pvt Ltd)
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives
    • 9.5.10. CENTOGENE GmbH
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Carrier Screening Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 5 Global Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 6 Global Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 7 Global Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 North America Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 10 North America Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 11 North America Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 12 North America Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 14 U.S. Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 15 U.S. Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 16 U.S. Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 18 Canada Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 19 Canada Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 20 Canada Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 22 Mexico Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 23 Mexico Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 24 Mexico Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 27 Europe Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Europe Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 29 Europe Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 31 UK Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 32 UK Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 33 UK Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 35 Germany Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 36 Germany Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 37 Germany Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 39 France Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 40 France Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 41 France Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 43 Italy Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 44 Italy Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 45 Italy Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 47 Spain Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 48 Spain Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 49 Spain Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Sweden Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 51 Sweden Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 52 Sweden Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 53 Sweden Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Norway Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 55 Norway Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 56 Norway Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 57 Norway Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 59 Denmark Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 60 Denmark Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 61 Denmark Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 65 Asia-Pacific Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 68 Japan Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 69 Japan Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 70 Japan Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 72 China Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 73 China Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 74 China Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 76 India Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 77 India Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 78 India Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 80 Australia Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 81 Australia Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 82 Australia Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 Thailand Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 84 Thailand Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 85 Thailand Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 86 Thailand Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 South Korea Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 88 South Korea Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 89 South Korea Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 90 South Korea Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 93 Latin America Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Latin America Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 95 Latin America Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 97 Brazil Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 98 Brazil Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 99 Brazil Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 101 Argentina Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 102 Argentina Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 103 Argentina Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 MIDDLE EAST & AFRICA Carrier Screening Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 MIDDLE EAST & AFRICA Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 106 MIDDLE EAST & AFRICA Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 107 MIDDLE EAST & AFRICA Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 108 Middle East & Africa Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 110 South Africa Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 111 South Africa Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 112 South Africa Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 118 UAE Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 119 UAE Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 120 UAE Carrier Screening Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Carrier Screening Market, By Medical Conditions, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Carrier Screening Market, By Type, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Carrier Screening Market, By Technology, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Carrier Screening Market, By End Use, 32021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Market summary
  • Fig. 4 Market segmentation & scope
  • Fig. 5 Market size and growth prospects
  • Fig. 6 Global carrier screening market- Key market driver analysis
  • Fig. 7 Global carrier screening market - Key market restraint analysis
  • Fig. 8 Penetration & growth prospect mapping
  • Fig. 9 Global carrier screening market - Porter's analysis
  • Fig. 10 Global carrier screening market - PESTEL analysis
  • Fig. 11 Global carrier screening market Medical Conditions outlook key takeaways
  • Fig. 12 Global carrier screening market: Medical Conditions movement analysis
  • Fig. 13 Spinal muscular Atrophy market estimates, 2021 - 2033 (USD Million)
  • Fig. 14 Cystic fibrosis market estimates, 2021 - 2033 (USD Million)
  • Fig. 15 Tay-Sachs market estimates, 2021 - 2033 (USD Million)
  • Fig. 16 Gaucher disease market estimates, 2021 - 2033 (USD Million)
  • Fig. 17 Sickle cell disease market estimates, 2021 - 2033 (USD Million)
  • Fig. 18 Others market estimates, 2021 - 2033 (USD Million)
  • Fig. 19 Global carrier screening market technology outlook key takeaways
  • Fig. 20 Global carrier screening market: technology movement analysis
  • Fig. 21 Expanded carrier screening market estimates, 2021 - 2033 (USD Million)
  • Fig. 22 Targeted disease carrier screening market estimates, 2021 - 2033 (USD Million)
  • Fig. 23 Global carrier screening market technology outlook key takeaways
  • Fig. 24 Global carrier screening market technology movement analysis
  • Fig. 25 DNA sequencing market estimates, 2021 - 2033 (USD Million)
  • Fig. 26 Polymerase chain reaction market estimates, 2021 - 2033 (USD Million)
  • Fig. 27 Microarrays market estimates, 2021 - 2033 (USD Million)
  • Fig. 28 Other technologies (MLPA, genotyping, enzyme screening) market estimates, 2021 - 2033 (USD Million)
  • Fig. 29 Global carrier screening market end use outlook key takeaways
  • Fig. 30 Global carrier screening market end use movement analysis
  • Fig. 31 Hospitals market estimates, 2021 - 2033 (USD Million)
  • Fig. 32 Laboratories market estimates, 2021 - 2033 (USD Million)
  • Fig. 33 Physician offices & clinics market estimates, 2021 - 2033 (USD Million)
  • Fig. 34 Other end users market estimates, 2021 - 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 Global Carrier Screening Market: Regional movement analysis
  • Fig. 37 North America Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 38 U.S. Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 39 Canada Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 40 Mexico Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 41 Europe Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 42 UK Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 43 Germany Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 44 France Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 46 Italy Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 47 Denmark Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 48 Sweden Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 49 Norway Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 50 Asia Pacific Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 51 Japan Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 52 China Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 53 India Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 54 South Korea Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 55 Australia Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 56 Thailand Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 57 Latin America Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 58 Brazil Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 59 Argentina Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 60 Middle East & Africa Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 61 South Africa Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 62 Saudi Arabia Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 63 UAE Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 64 Kuwait Carrier Screening Market, 2021 - 2033 (USD Million)
  • Fig. 65 Strategy framework